BTK Degrader Study Shows Promise for a New Class of CLL Therapies | Alexey Danilov MD PhD | #ASH2024

7 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Dr Alexey Danilov presents a study on two promising BTK degraders for patients with CLL.

Link to ASH playlist: https://healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b

ASH Abstract: Nx-2127 and Nx-5948, Two Clinical Stage Cereblon-Recruiting BTK Degraders, Facilitate T Cell Functionality in Chronic Lymphocytic Leukemia

#ASH24 #CLL #leusm

Follow HealthTree: https://linktr.ee/HealthTreeUniversity
Category
Oncology
Be the first to comment

Up Next